← Back to headlines
Intellia Outlines 2026 Lonvo-z Launch Plans After FDA Lifts Clinical Hold
Intellia Therapeutics has detailed its plans for the 2026 launch of lonvo-z, following the FDA's decision to lift the clinical hold on its MAGNITUDE-2 trial.
27 Feb, 02:48 — 27 Feb, 02:48
ℹOnly 1 source covers this story
